These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 31708447)

  • 1. A support programme for secondary prevention in patients with transient ischaemic attack and minor stroke (INSPiRE-TMS): an open-label, randomised controlled trial.
    Ahmadi M; Laumeier I; Ihl T; Steinicke M; Ferse C; Endres M; Grau A; Hastrup S; Poppert H; Palm F; Schoene M; Seifert CL; Kandil FI; Weber JE; von Weitzel-Mudersbach P; Wimmer MLJ; Algra A; Amarenco P; Greving JP; Busse O; Köhler F; Marx P; Audebert HJ
    Lancet Neurol; 2020 Jan; 19(1):49-60. PubMed ID: 31708447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-Centered Outcomes in a Randomized Trial Investigating a Multimodal Prevention Program After Transient Ischemic Attack or Minor Stroke: The INSPiRE-TMS Trial.
    Ihl T; Ahmadi M; Laumeier I; Steinicke M; Ferse C; Klyscz P; Endres M; Hastrup S; Poppert H; Palm F; Kandil FI; Weber JE; von Weitzel-Mudersbach P; Wimmer MLJ; Audebert HJ
    Stroke; 2022 Sep; 53(9):2730-2738. PubMed ID: 35703097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial.
    Kelly P; Lemmens R; Weimar C; Walsh C; Purroy F; Barber M; Collins R; Cronin S; Czlonkowska A; Desfontaines P; De Pauw A; Evans NR; Fischer U; Fonseca C; Forbes J; Hill MD; Jatuzis D; Kõrv J; Kraft P; Kruuse C; Lynch C; McCabe D; Mikulik R; Murphy S; Nederkoorn P; O'Donnell M; Sandercock P; Schroeder B; Shim G; Tobin K; Williams DJ; Price C
    Lancet; 2024 Jul; 404(10448):125-133. PubMed ID: 38857611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensified secondary prevention intending a reduction of recurrent events in TIA and minor stroke patients (INSPiRE-TMS): a protocol for a randomised controlled trial.
    Leistner S; Michelson G; Laumeier I; Ahmadi M; Smyth M; Nieweler G; Doehner W; Sobesky J; Fiebach JB; Marx P; Busse O; Köhler F; Poppert H; Wimmer ML; Knoll T; Von Weitzel-Mudersbach P; Audebert HJ
    BMC Neurol; 2013 Jan; 13():11. PubMed ID: 23347503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.
    Toyoda K; Uchiyama S; Yamaguchi T; Easton JD; Kimura K; Hoshino H; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K;
    Lancet Neurol; 2019 Jun; 18(6):539-548. PubMed ID: 31122494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
    Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
    Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial.
    Hankey GJ; Eikelboom JW; Yi Q; Lees KR; Chen C; Xavier D; Navarro JC; Ranawaka UK; Uddin W; Ricci S; Gommans J; Schmidt R;
    Lancet Neurol; 2012 Jun; 11(6):512-20. PubMed ID: 22554931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (MonDAFIS): a randomised, open-label, multicentre study.
    Haeusler KG; Kirchhof P; Kunze C; Tütüncü S; Fiessler C; Malsch C; Olma MC; Jawad-Ul-Qamar M; Krämer M; Wachter R; Michalski D; Kraft A; Rizos T; Gröschel K; Thomalla G; Nabavi DG; Röther J; Laufs U; Veltkamp R; Heuschmann PU; Endres M;
    Lancet Neurol; 2021 Jun; 20(6):426-436. PubMed ID: 34022169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of subsequent disabling or fatal stroke in patients with transient ischaemic attack or minor ischaemic stroke: an international, prospective cohort study.
    Hobeanu C; Lavallée PC; Charles H; Labreuche J; Albers GW; Caplan LR; Donnan GA; Ferro JM; Hennerici MG; Molina CA; Rothwell PM; Steg PG; Touboul PJ; Uchiyama S; Vicaut E; Wong KSL; Amarenco P;
    Lancet Neurol; 2022 Oct; 21(10):889-898. PubMed ID: 36115361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial.
    ; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
    Lancet Neurol; 2007 Feb; 6(2):115-24. PubMed ID: 17239798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial.
    Ueki K; Sasako T; Okazaki Y; Kato M; Okahata S; Katsuyama H; Haraguchi M; Morita A; Ohashi K; Hara K; Morise A; Izumi K; Ishizuka N; Ohashi Y; Noda M; Kadowaki T;
    Lancet Diabetes Endocrinol; 2017 Dec; 5(12):951-964. PubMed ID: 29079252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials.
    Rothwell PM; Algra A; Chen Z; Diener HC; Norrving B; Mehta Z
    Lancet; 2016 Jul; 388(10042):365-375. PubMed ID: 27209146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary prevention with a structured semi-interactive stroke prevention package in INDIA (SPRINT INDIA): a multicentre, randomised controlled trial.
    SPRINT INDIA trial collaborators
    Lancet Glob Health; 2023 Mar; 11(3):e425-e435. PubMed ID: 36796986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a Discharge Educational Strategy vs Standard Discharge Care on Reduction of Vascular Risk in Patients With Stroke and Transient Ischemic Attack: The DESERVE Randomized Clinical Trial.
    Boden-Albala B; Goldmann E; Parikh NS; Carman H; Roberts ET; Lord AS; Torrico V; Appleton N; Birkemeier J; Parides M; Quarles L
    JAMA Neurol; 2019 Jan; 76(1):20-27. PubMed ID: 30304326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial.
    Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox KM; Hennerici MG; Mattle HP; Rothwell PM; de Cordoüe A; Fratacci MD;
    Lancet; 2011 Jun; 377(9782):2013-22. PubMed ID: 21616527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Program of rehabilitative exercise and education to avert vascular events after non-disabling stroke or transient ischemic attack (PREVENT Trial): a multi-centred, randomised controlled trial.
    MacKay-Lyons M; Gubitz G; Giacomantonio N; Wightman H; Marsters D; Thompson K; Blanchard C; Eskes G; Thornton M
    BMC Neurol; 2010 Dec; 10():122. PubMed ID: 21143864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early rhythm-control therapy for atrial fibrillation in patients with a history of stroke: a subgroup analysis of the EAST-AFNET 4 trial.
    Jensen M; Suling A; Metzner A; Schnabel RB; Borof K; Goette A; Haeusler KG; Zapf A; Wegscheider K; Fabritz L; Diener HC; Thomalla G; Kirchhof P
    Lancet Neurol; 2023 Jan; 22(1):45-54. PubMed ID: 36517170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial.
    VITATOPS Trial Study Group
    Lancet Neurol; 2010 Sep; 9(9):855-65. PubMed ID: 20688574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rehabilitation of patients after transient ischaemic attack or minor stroke: pilot feasibility randomised trial of a home-based prevention programme.
    Heron N; Kee F; Mant J; Cupples ME; Donnelly M
    Br J Gen Pract; 2019 Oct; 69(687):e706-e714. PubMed ID: 31501165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial.
    Compter A; van der Worp HB; Schonewille WJ; Vos JA; Boiten J; Nederkoorn PJ; Uyttenboogaart M; Lo RT; Algra A; Kappelle LJ;
    Lancet Neurol; 2015 Jun; 14(6):606-14. PubMed ID: 25908089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.